Nicholas Lydon
For the development of molecularly-targeted treatments for chronic myeloid leukemia, converting a fatal cancer into a manageable chronic condition.
Afiliado al momento del premio
Basel, Suiza
Reconocimiento al trabajo con impacto duradero
For the development of molecularly-targeted treatments for chronic myeloid leukemia, converting a fatal cancer into a manageable chronic condition.
Basel, Suiza